Hisakazu Mihara

Hisakazu Mihara

Auto-generated profile, based on publicly available information

Hisakazu Mihara

School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2008 in Accounts of Chemical Research
Verified
Journal Article
Closed access
TTTsuyoshi Takahashi
Tsuyoshi Takahashi
HMHisakazu Mihara
Hisakazu Mihara

24 April 2015 in BioTech
Verified
Journal Article
Open access
PDF file
ASAmir Syahir
Amir Syahir
Kenji UsuiKenji Usui
Kenji Usui
Kin-ya TomizakiKin-ya Tomizaki
Kin-ya Tomizaki
KKKotaro Kajikawa
Kotaro Kajikawa
HMHisakazu Mihara
Hisakazu Mihara
Protein microarray technology has gone through numerous innovative developments in recent decades. In this review, we focus on the development of protein detection methods embedded in the technology. Early microarrays utilized useful chromophores and versatile biochemical techniques dominated by high-throughput illumination. Recently, the realization of label-free techniques has been greatly advanced by the combination of knowledge in material sciences, computational design and nanofabrication. These rapidly advancing techniques aim to provide data without the intervention of label molecules. Here, we present a brief overview of this remarkable innovation from the perspectives of label and label-free techniques in transducing nano‑biological events.

22 April 2005 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
KTKin‐Ya Tomizaki
Kin‐Ya Tomizaki
Kenji UsuiKenji Usui
Kenji Usui
HMHisakazu Mihara
Hisakazu Mihara

1 June 1997 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TNTakuro Niidome
Takuro Niidome
NONaoya Ohmori
Naoya Ohmori
AIAkitoyo Ichinose
Akitoyo Ichinose
AWAkihiro Wada
Akihiro Wada
HMHisakazu Mihara
Hisakazu Mihara
HAHaruhiko Aoyagi
Haruhiko Aoyagi
Polycationic reagents such as cationic lipids and poly-l-lysine are widely used for gene transfer into cells in vitro and show promise as vectors for in vivo gene therapy applications as nonviral gene transfer techniques. We have developed a novel transfection method using cationic amphiphilic α-helical oligopeptides with repeated sequences. Oligopeptide has the advantages of being easily designed and modified because of its simple structure. In this study, we synthesized five kinds of peptides of which the total chain length and the width of the hydrophobic region were changed. The binding of the peptides to plasmid DNA was evaluated by agarose gel electrophoresis. It was found that the long and/or hydrophobic peptides can strongly bind to the DNA. The formation of large aggregates with a 0.5–5-μm diameter, which consisted of the long peptides and the DNA, was observed by electron microscopy. The transfection abilities of the peptides were determined by the expression of luciferase from its cDNA in COS-7 cells. The long peptides showed high transfection abilities. As a result, it could be said that the transfection ability of these peptides was parallel to their ability to form aggregates with DNA. Furthermore, the transfection ability was increased by the addition of chloroquine in the transfection procedure. This result indicated that the internalization of the peptide-DNA aggregates would be mediated by the endocytosis pathway.

22 December 2009 in Biochemistry
Verified
Journal Article
Closed access
TSTempei Shimizu
Tempei Shimizu
YKYasushi Kanamori
Yasushi Kanamori
TFTakao Furuki
Takao Furuki
Takahiro KikawadaTakahiro Kikawada
Takahiro Kikawada
TOTakashi Okuda
Takashi Okuda
MSMinoru Sakurai
Minoru Sakurai

13 January 1989 in Science
Verified
Journal Article
Closed access
PDF file
EKEmil Thomas Kaiser
Emil Thomas Kaiser
HMHisakazu Mihara
Hisakazu Mihara
GLGenevieve A. Laforet
Genevieve A. Laforet
JKJeffery W. Kelly
Jeffery W. Kelly
LWLee Walters
Lee Walters
TSTomikazu Sasaki
Tomikazu Sasaki
The chemical synthesis of biologically active peptides and polypeptides can be achieved by using a convergent strategy of condensing protected peptide segments to form the desired molecule. An oxime support increases the ease with which intermediate protected peptides can be synthesized and makes this approach useful for the synthesis of peptides in which secondary structural elements have been redesigned. The extension of these methods to large peptides and proteins, for which folding of secondary structures into functional tertiary structures is critical, is discussed. Models of apolipoproteins, the homeo domain from the developmental protein encoded by the Antennapedia gene of Drosophila , a part of the Cro repressor, and the enzyme ribonuclease T 1 and a structural analog have been synthesized with this method.